QDEL Jun 2024 55.000 call
- Insider Monkey
QuidelOrtho Corporation (QDEL) is Excited about the New Product Launch
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Small Cap Growth Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here. The market rally continued in the first quarter of 2024, supported by positive inflation data and robust economic signs. The fund returned 6.04% (net) in the first quarter […]
- Insider Monkey
QuidelOrtho (QDEL) Trembled on Disappointing Guidance
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Value Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here. The firm focuses on companies with strong balance sheets and attractive cash flows with compelling valuations rather than following market trends. The strategy outperformed the benchmark Russell 2000 Value […]
- Business Wire
QuidelOrtho to Participate in 44th Annual William Blair Growth Stock Conference
SAN DIEGO, May 23, 2024--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced that members of its management team are scheduled to participate in the 44th Annual William Blair Growth Stock Conference on June 5, 2024, in Chicago, IL.
